Compounds > bromodeoxyuridine
Page last updated: 2024-08-17

bromodeoxyuridine and Human T-lymphotropic Virus 1 Infection

bromodeoxyuridine has been researched along with Human T-lymphotropic Virus 1 Infection in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asquith, B; Bangham, C; Burny, A; Debacq, C; Héraud, JM; Kazanji, M; Kettmann, R; Merien, F; Mortreux, F; Moules, V; Wattel, E; Willems, L1

Other Studies

1 other study(ies) available for bromodeoxyuridine and Human T-lymphotropic Virus 1 Infection

ArticleYear
Reduced cell turnover in lymphocytic monkeys infected by human T-lymphotropic virus type 1.
    Oncogene, 2005, Nov-17, Volume: 24, Issue:51

    Topics: Animals; Antimetabolites; Bromodeoxyuridine; CD4-Positive T-Lymphocytes; Cell Proliferation; Disease Models, Animal; HTLV-I Infections; Human T-lymphotropic virus 1; Leukemia; Lymphocyte Count; Male; Saimiri

2005